Eligibility Details:
- INCLUSION CRITERIA:
- Age 20 - 39 years or age 70 years and older
- Healthy (see exclusion criteria below)
- Are able to understand the study risks and procedures, and consent to participate in
the study.
- Are able to read and speak English.
- Caucasian or Africian American
- Previous enrolled participants.
EXCLUSION CRITERIA (SCREENING VISIT):
- A medical condition that requires the use of chronic anticoagulant medication use such
as warfarin, clopidogrel, heparin or antiplatelet agents other than low dose aspirin
(81mg).
- History of increased bleeding due to either a known medical condition or an
undiagnosed cause.
- A medical condition that causes impaired wound healing such as diabetes.
- Current androgenic/anabolic and/or corticosteroid use or use within 90 days of the
procedure (ocular corticosteroid use okay).
- Current antibiotic or anti-viral use or use within 60 days of the procedure.
- Active infections or chronic skin conditions that would prevent access to the biopsy
area.
- Taking non-steroidal anti-inflammatory agents (NSAIDs) such as Motrin (Ibuprofen),
Advil (Ibuprofen) or Naprosyn (Naproxen) and the
participant is unable to stop taking them 3 days before the biopsy and 1 day after the
biopsy procedure.
- Taking more than 81 mg of aspirin a day and the participant is unable to stop taking
it for 3 days before the biopsy and 1 day after the biopsy procedure.
- Allergic to Lidocaine (Xylocaine) or any other local anesthetic or the participant has
had in the past a severe allergic reaction to similar drugs.
- Allergic to topical betadine solution.
- Severe allergy to adhesives found in tape.
- HIV virus infection.
- Hepatitis B or C or exposure within 6 months of visit.
- History of diabetes (requiring any medical treatment other than diet and exercise) or
fasting plasma glucose is greater than or equal to 126 mg/dL or HbA1c greater than or
equal to 6.5%.
- Clinically significant hormonal dysfunction (self-reported or laboratory values out of
range. Mild hypothyroidism (TSH < 10 microIU/mL) in participants over 60 is not
considered exclusion).
- Kidney disease (Creatinine >1.5 mg/dl or calculated creatinine clearance < 50 cc/min)
- Liver disease (Bilirubin > 1.5 mg/dl (unless higher levels can be ascribed to Gilbert
s disease); ALT, AST or alkaline phosphatase twice the normal serum concentration)
- Severe gastrointestinal diseases such as Crohn s disease or ulcerative colitis
requiring continuous treatment.
- History of severe pulmonary disease such as chronic obstructive pulmonary disease
(COPD) or asthma requiring continuous medication use.
- History of severe psychiatric conditions associated with behavioral problems or
requiring chronic medical treatment.
- Currently pregnant or breastfeeding.
- Participants with history of skin keloid formation during wound healing
- Current illness that as judged by the study physician substantially increases the
risks associated the skin biopsy(s) (active infections, allergies, etc.).